BUSINESS● LOWAug 5 · Aug 5, 2026, 10:00 PM
Tenaya Therapeutics GAAP EPS of -$0.20 misses by $0.13, revenue of $1.11M misses by $8.89M
Seeking Alpha Tech
Tenaya Therapeutics reported GAAP EPS of -$0.20, missing estimates by $0.13, and revenue of $1.11M, which also missed expectations by $8.89M. This indicates the company's financial performance fell short of analyst projections.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS36m agoMercantile Bank Non-GAAP EPS of $1.42 beats by $0.07, revenue of $73.2M beats by $2.36MSeeking Alpha TechBUSINESS39m agoMaersk, Hateco sign deal for $3.5B rail terminal network in northern VietnamSeeking Alpha Tech